<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ventricular tachyarrhythmias are common consequences of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>During the prehospital phase of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (MI), <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced electrophysiological changes and genetic factors are responsible for their occurrence, but the precise pathophysiologic mechanisms are ill-understood </plain></SENT>
<SENT sid="2" pm="."><plain>Primary percutaneous coronary interventions (PCIs) have decreased the incidence of ventricular tachyarrhythmias during subsequent stages, and future treatments ameliorating reperfusion injury may provide further progress </plain></SENT>
<SENT sid="3" pm="."><plain>In the <z:hpo ids='HP_0011010'>chronic</z:hpo> phase, antiarrhythmic drug therapy targeted toward arrhythmogenic substrate has relatively limited value, but alternative approaches are still uncertain </plain></SENT>
<SENT sid="4" pm="."><plain>By contrast, prompt <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> termination by implantable cardioverter-defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e>) is highly effective, although risk-stratification algorithms in candidate patients are inadequate </plain></SENT>
<SENT sid="5" pm="."><plain>This review explores current views in the pathophysiology and treatment of ventricular tachyarrhythmias at different clinical stages </plain></SENT>
</text></document>